Towa Pharmaceutical Co.,Ltd. Stock: price and insider trades · Japan
東和薬品株式会社
Towa Pharmaceutical Co.,Ltd.: what insiders have been doing
Towa Pharmaceutical Co.,Ltd. belongs to the Health Care sector. Filings by its managers are published through EDINET (Japan FSA). The last twelve months, up to 10 November 2026, brought 2 filings signed by 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought Towa Pharmaceutical Co.,Ltd. shares on the open market in the past twelve months.
With 2 filings in twelve months, the company is quieter than the median of 3 filings across the 3,419 companies we follow on the same exchange.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Analyst consensus: bullish or bearish?
Analysts rate Towa Pharmaceutical Co.,Ltd. Strong Buy (bullish), based on 6 analysts. Average price target: JP¥5,350.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- ShareXTKSEDINET:S100YOTO
- ShareXTKSEDINET:S100XJ2X
- 100.0% of flowShareXTKSEDINET:S100QTZZ
3 of 3 declarations
About Towa Pharmaceutical Co.,Ltd.
Towa Pharmaceutical Co., Ltd. is a Japanese company specializing in the pharmaceutical sector. It focuses on the research, development, and marketing of medications.
